Related references
Note: Only part of the references are listed.Effects of Δ40p53, an isoform of p53 lacking the N-terminus, on transactivation capacity of the tumor suppressor protein p53
Hind Hafsi et al.
BMC CANCER (2013)
Replication of GWAS-identified neuroblastoma risk loci strengthens the role of BARD1 and affirms the cumulative effect of genetic variations on disease susceptibility
Mario Capasso et al.
CARCINOGENESIS (2013)
EGFR Mutation-Induced Alternative Splicing of Max Contributes to Growth of Glycolytic Tumors in Brain Cancer
Ivan Babic et al.
CELL METABOLISM (2013)
The development and application of small molecule modulators of SF3b as therapeutic agents for cancer
Thomas R. Webb et al.
DRUG DISCOVERY TODAY (2013)
Downregulation of splicing factor SRSF3 induces p53β, an alternatively spliced isoform of p53 that promotes cellular senescence
Y. Tang et al.
ONCOGENE (2013)
Expression of oncogenic BARD1 isoforms affects colon cancer progression and correlates with clinical outcome
Y-Q Zhang et al.
BRITISH JOURNAL OF CANCER (2012)
Common Variation at BARD1 Results in the Expression of an Oncogenic Isoform That Influences Neuroblastoma Susceptibility and Oncogenicity
Kristopher R. Bosse et al.
CANCER RESEARCH (2012)
BARD1: An independent predictor of survival in non-small cell lung cancer
Yong-Qiang Zhang et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Androgen Receptor Splice Variants Activate Androgen Receptor Target Genes and Support Aberrant Prostate Cancer Cell Growth Independent of Canonical Androgen Receptor Nuclear Localization Signal
Siu Chiu Chan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Tissue-Specific Alternative Splicing Remodels Protein-Protein Interaction Networks
Jonathan D. Ellis et al.
MOLECULAR CELL (2012)
Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
Ravid Straussman et al.
NATURE (2012)
Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors
Timothy R. Wilson et al.
NATURE (2012)
The spliceosome as a target of novel antitumour drugs
Sophie Bonnal et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Intronic splicing enhancers, cognate splicing factors and context-dependent regulation rules
Yang Wang et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2012)
Circular RNAs Are the Predominant Transcript Isoform from Hundreds of Human Genes in Diverse Cell Types
Julia Salzman et al.
PLOS ONE (2012)
Sudemycins, Novel Small Molecule Analogues of FR901464, Induce Alternative Gene Splicing
Liying Fan et al.
ACS CHEMICAL BIOLOGY (2011)
Exon array analysis reveals neuroblastoma tumors have distinct alternative splicing patterns according to stage and MYCN amplification status
Xiang Guo et al.
BMC MEDICAL GENOMICS (2011)
Distinct p53 Transcriptional Programs Dictate Acute DNA-Damage Responses and Tumor Suppression
Colleen A. Brady et al.
CELL (2011)
BARD1 Expression Predicts Outcome in Colon Cancer
Judith C. Sporn et al.
CLINICAL CANCER RESEARCH (2011)
Splicing factor hnRNPH drives an oncogenic splicing switch in gliomas
Clare V. LeFave et al.
EMBO JOURNAL (2011)
Reduced fidelity of branch point recognition and alternative splicing induced by the anti-tumor drug spliceostatin A
Anna Corrionero et al.
GENES & DEVELOPMENT (2011)
The anti-tumor drug E7107 reveals an essential role for SF3b in remodeling U2 snRNP to expose the branch point-binding region
Eric G. Folco et al.
GENES & DEVELOPMENT (2011)
Integrative genomics identifies LMO1 as a neuroblastoma oncogene
Kai Wang et al.
NATURE (2011)
RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)
Poulikos I. Poulikakos et al.
NATURE (2011)
Frequent pathway mutations of splicing machinery in myelodysplasia
Kenichi Yoshida et al.
NATURE (2011)
Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model
Yimin Hua et al.
NATURE (2011)
Functional consequences of developmentally regulated alternative splicing
Auinash Kalsotra et al.
NATURE REVIEWS GENETICS (2011)
Androgen Receptor Variants Occur Frequently in Castration Resistant Prostate Cancer Metastases
Xiaotun Zhang et al.
PLOS ONE (2011)
A Snapshot of the Expression Signature of Androgen Receptor Splicing Variants and Their Distinctive Transcriptional Activities
Rong Hu et al.
PROSTATE (2011)
DEGRADE, MOVE, REGROUP: signaling control of splicing proteins
Florian Heyd et al.
TRENDS IN BIOCHEMICAL SCIENCES (2011)
p53 mutant breast cancer patients expressing p53 gamma have as good a prognosis as wild-type p53 breast cancer patients
Jean-Christophe Bourdon et al.
BREAST CANCER RESEARCH (2011)
Deregulated expression of hnRNP A/B proteins in human non-small cell lung cancer: parallel assessment of protein and mRNA levels in paired tumour/non-tumour tissues
Georgios Boukakis et al.
BMC CANCER (2010)
Spliceostatin A blocks angiogenesis by inhibiting global gene expression including VEGF
Ryohei Furumai et al.
CANCER SCIENCE (2010)
Δ160p53 is a novel N-terminal p53 isoform encoded by Δ133p53 transcript
Virginie Marcel et al.
FEBS LETTERS (2010)
Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged
Charles J. David et al.
GENES & DEVELOPMENT (2010)
Spinal muscular atrophy: mechanisms and therapeutic strategies
Christian L. Lorson et al.
HUMAN MOLECULAR GENETICS (2010)
Identification of Novel Truncated Androgen Receptor (AR) Mutants Including Unreported Pre-mRNA Splicing Variants in the 22Rv1 Hormone-Refractory Prostate Cancer (PCa) Cell Line
Gemma Marcias et al.
HUMAN MUTATION (2010)
Negative feedback loop of BRCA1-BARD1 ubiquitin ligase on estrogen receptor alpha stability and activity antagonized by cancer-associated isoform of BARD1
Eva Dizin et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2010)
Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant
Shihua Sun et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer
Charles J. David et al.
NATURE (2010)
Melanomas acquire resistance toB-RAF(V600E) inhibition by RTK or N-RAS upregulation
Ramin Nazarian et al.
NATURE (2010)
Alternative splicing and evolution: diversification, exon definition and function
Hadas Keren et al.
NATURE REVIEWS GENETICS (2010)
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
Keith T. Flaherty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
p53 regulates the transcription of its Δ133p53 isoform through specific response elements contained within the TP53 P2 internal promoter
V. Marcel et al.
ONCOGENE (2010)
Alternative splicing of p53 and p73: the novel p53 splice variant p53δ is an independent prognostic marker in ovarian cancer
G. Hofstetter et al.
ONCOGENE (2010)
Disturbed Expression of Splicing Factors in Renal Cancer Affects Alternative Splicing of Apoptosis Regulators, Oncogenes, and Tumor Suppressors
Agnieszka Piekielko-Witkowska et al.
PLOS ONE (2010)
Dynamic transcriptomes during neural differentiation of human embryonic stem cells revealed by short, long, and paired-end sequencing
Jia Qian Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor
Philip A. Watson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Distinct Roles of BARD1 Isoforms in Mitosis: Full-Length BARD1 Mediates Aurora B Degradation, Cancer-Associated BARD1β Scaffolds Aurora B and BRCA2
Stephan Ryser et al.
CANCER RESEARCH (2009)
Antitumor Activity with CYP17 Blockade Indicates That Castration-Resistant Prostate Cancer Frequently Remains Hormone Driven
Gerhardt Attard et al.
CANCER RESEARCH (2009)
A Novel Androgen Receptor Splice Variant Is Up-regulated during Prostate Cancer Progression and Promotes Androgen Depletion-Resistant Growth
Zhiyong Guo et al.
CANCER RESEARCH (2009)
Ligand-Independent Androgen Receptor Variants Derived from Splicing of Cryptic Exons Signify Hormone-Refractory Prostate Cancer
Rong Hu et al.
CANCER RESEARCH (2009)
The Spliceosome: Design Principles of a Dynamic RNP Machine
Markus C. Wahl et al.
CELL (2009)
Starving the Addiction: New Opportunities for Durable Suppression of AR Signaling in Prostate Cancer
Karen E. Knudsen et al.
CLINICAL CANCER RESEARCH (2009)
p53 isoform Δ113p53 is a p53 target gene that antagonizes p53 apoptotic activity via BclxL activation in zebrafish
Jun Chen et al.
GENES & DEVELOPMENT (2009)
p53 isoforms Δ133p53 and p53β are endogenous regulators of replicative cellular senescence
Kaori Fujita et al.
NATURE CELL BIOLOGY (2009)
Common variations in BARD1 influence susceptibility to high-risk neuroblastoma
Mario Capasso et al.
NATURE GENETICS (2009)
Cancer-associated regulation of alternative splicing
Julian P. Venables et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2009)
Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
Chris Tran et al.
SCIENCE (2009)
CD95, BIM and T cell homeostasis
Philippe Bouillet et al.
NATURE REVIEWS IMMUNOLOGY (2009)
The first 30 years of p53: growing ever more complex
Arnold J. Levine et al.
NATURE REVIEWS CANCER (2009)
Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance
Scott M. Dehm et al.
CANCER RESEARCH (2008)
Small molecular weight variants of p53 are expressed in human melanoma cells and are induced by the DNA-damaging agent cisplatin
Kelly A. Avery-Kiejda et al.
CLINICAL CANCER RESEARCH (2008)
Expression levels of p53 and p73 isoforms in stage I and stage III ovarian cancer
Mirko Marabese et al.
EUROPEAN JOURNAL OF CANCER (2008)
Alternative splicing in colon, bladder, and prostate cancer identified by exon array analysis
Kasper Thorsen et al.
MOLECULAR & CELLULAR PROTEOMICS (2008)
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Heather R. Christofk et al.
NATURE (2008)
Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing
Qun Pan et al.
NATURE GENETICS (2008)
Oncogenic BARD1 isoforms expressed in gynecological cancers
Lin Li et al.
CANCER RESEARCH (2007)
Evidence for calpain-mediated androgen receptor cleavage as a mechanism for androgen independence
Stephen J. Libertini et al.
CANCER RESEARCH (2007)
A splicing variant of the androgen receptor detected in a metastatic prostate cancer exhibits exclusively cytoplasmic actions
Monika Jagla et al.
ENDOCRINOLOGY (2007)
Splicing factor SF3b as a target of the antitumor natural product pladienolide
Yoshihiko Kotake et al.
NATURE CHEMICAL BIOLOGY (2007)
Spliceostatin A targets SF3b and inhibits both splicing and nuclear retention of pre-mRNA
Daisuke Kaida et al.
NATURE CHEMICAL BIOLOGY (2007)
Correction: Discovery and analysis of evolutionarily conserved intronic splicing regulatory elements
Gene W. Yeo et al.
PLOS GENETICS (2007)
Discovery and analysis of evolutionarily conserved intronic splicing regulatory elements
Gene W. Yeo et al.
PLOS GENETICS (2007)
Meta-analysis of BRCA1 and BRCA2 penetrance
Sining Chen et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
The gene encoding the splicing factor SF2/ASF is a proto-oncogene
Rotem Karni et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2007)
Drug Insight: role of the androgen receptor in the development and progression of prostate cancer
Mary-Ellen Taplin
NATURE CLINICAL PRACTICE ONCOLOGY (2007)
Intron size, abundance, and distribution within untranslated regions of genes
Xin Hong et al.
MOLECULAR BIOLOGY AND EVOLUTION (2006)
Activation of α-tropomyosin exon 2 is regulated by the SR protein 9GS and heterogeneous nuclear ribonucleoproteins H and F
J. Barrett Crawford et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Expression of p53 and p53/47 are controlled by alternative mechanisms of messenger RNA translation initiation
M. M. Candeias et al.
ONCOGENE (2006)
Is there more to BARD1 than BRCA1?
I Irminger-Finger et al.
NATURE REVIEWS CANCER (2006)
Aberrant expression of BARD1 in breast and ovarian cancers with poor prognosis
JY Wu et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
A truncated splice variant of human BARD1 that lacks the RING finger and ankyrin repeats
M Tsuzuki et al.
CANCER LETTERS (2006)
Regulation of CD44 alternative splicing by SRm160 and its potential role in tumor cell invasion
CH Cheng et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress
F. Murray-Zmijewski et al.
CELL DEATH AND DIFFERENTIATION (2006)
Soluble Fas receptor and soluble Fas ligand in the serum of women with uterine tumors
Z Kondera-Anasz et al.
APOPTOSIS (2005)
p53 isoforms can regulate p53 transcriptional activity
JC Bourdon et al.
GENES & DEVELOPMENT (2005)
Inactivation of the SR protein splicing factor ASF/SF2 results in genomic instability
XL Li et al.
CELL (2005)
Pyruvate kinase type M2 and its role in tumor growth and spreading
S Mazurek et al.
SEMINARS IN CANCER BIOLOGY (2005)
BARD1 induces apoptosis by catalysing phosphorylation of p53 by DNA-damage response kinase
A Feki et al.
ONCOGENE (2005)
Understanding alternative splicing: Towards a cellular code
AJ Matlin et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
Androgen receptor function is modulated by the tissue-specific AR45 variant
I Ahrens-Fath et al.
FEBS JOURNAL (2005)
Nuclear-cytoplasmic translocation of BARD1 is linked to its apoptotic activity
CE Jefford et al.
ONCOGENE (2004)
Identification of alternatively spliced mRNA variants related to cancers by genome-wide ESTs alignment
LJ Hui et al.
ONCOGENE (2004)
Structural basis of androgen receptor binding to selective androgen response elements
PL Shaffer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Pladienolides, new substances from culture of Streptomyces platensis Mer-11107 I.: Taxonomy, fermentation, isolation and screening
T Sakai et al.
JOURNAL OF ANTIBIOTICS (2004)
Mutation screening of the BARD1 gene:: evidence for involvement of the Cys557Ser allele in hereditary susceptibility to breast cancer -: art. no. e114
SM Karppinen et al.
JOURNAL OF MEDICAL GENETICS (2004)
Regulation of human p53 activity and cell localization by alternative splicing
A Ghosh et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
RESCUE-ESE identifies candidate exonic splicing enhancers in vertebrate exons
WG Fairbrother et al.
NUCLEIC ACIDS RESEARCH (2004)
Variation in sequence and organization of splicing regulatory elements in vertebrate genes
G Yeo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Discovery of novel splice forms and functional analysis of cancer-specific alternative splicing in human expressed sequences
Q Xu et al.
NUCLEIC ACIDS RESEARCH (2003)
Loss of Bard1, the heterodimeric partner of the Brca1 tumor suppressor, results in early embryonic lethality and chromosomal instability
EE McCarthy et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Circulating soluble Fas in patients with breast cancer
SM Sheen-Chen et al.
WORLD JOURNAL OF SURGERY (2003)
CD44: From adhesion molecules to signalling regulators
H Ponta et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)
ΔN-p53, a natural isoform of p53 lacking the first transactivation domain, counteracts growth suppression by wild-type p53
S Courtois et al.
ONCOGENE (2002)
Comprehensive proteomic analysis of the human spliceosome
ZL Zhou et al.
NATURE (2002)
Predictive identification of exonic splicing enhancers in human genes
WG Fairbrother et al.
SCIENCE (2002)
Germline mutations of the BRICA1-associated ring domain (BARD1) gene in breast and breast/ovarian families negative for BRCA1 and BRCA2 alterations
C Ghimenti et al.
GENES CHROMOSOMES & CANCER (2002)
Formation of the androgen receptor transcription complex
YF Shang et al.
MOLECULAR CELL (2002)
Identification of BARD1 as mediator between proapoptotic stress and p53-dependent apoptosis
I Irminger-Finger et al.
MOLECULAR CELL (2001)
Expression and role of Bcl-xL in human hepatocellular carcinomas
T Takehara et al.
HEPATOLOGY (2001)
Molecular basis of androgen insensitivity
AO Brinkmann
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2001)
The role of U2AF35 and U2AF65 in enhancer-dependent splicing
BR Graveley et al.
RNA (2001)
Structural evidence for ligand specificity in the binding domain of the human androgen receptor -: Implications for pathogenic gene mutations
PM Matias et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage
H Tanaka et al.
NATURE (2000)
Exonic splicing enhancer motif recognized by human SC35 under splicing conditions
HX Liu et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Share Paper
